CIP4 Antibodies

Santa Cruz Biotechnology features a diverse variety of CIP4 monoclonal antibodies for advanced research in cellular signaling and protein interactions. CIP4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIP4, or Cdc42-interacting protein 4, plays a crucial role in cytoskeletal organization and cellular morphology by interacting with the small GTPase Cdc42. CIP4 is essential for processes such as cell migration, adhesion, and the formation of membrane protrusions, making it significant in studies related to cancer metastasis and other diseases. Understanding CIP4 function can provide insights into the mechanisms of cell behavior and the development of therapeutic strategies. Researchers worldwide utilize CIP4 monoclonal antibodies to investigate cellular dynamics and signaling pathways. CIP4 monoclonal antibodies ensure reliable results across multiple experimental applications. CIP4 monoclonal antibodies enable detailed examination of protein localization and interactions in various cellular contexts. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic applications.